Molecular and structural aspects of clinically relevant mutations related to the approved non-nucleoside inhibitors of HIV-1 reverse transcriptase-Reference-Cited by-同舟云学术

Molecular and structural aspects of clinically relevant mutations related to the approved non-nucleoside inhibitors of HIV-1 reverse transcriptase

Published:2011-06 Issue:3 Volume:14 Page:141-149
ISSN:1368-7646
Container-title:Drug Resistance Updates
language:en
Short-container-title:Drug Resistance Updates

Author:

Alcaro Stefano,Alteri Claudia,Artese Anna,Ceccherini-Silberstein Francesca,Costa Giosuè,Ortuso Francesco,Parrotta Lucia,Perno Carlo Federico,Svicher Valentina

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Cancer Research,Pharmacology,Oncology

Reference115 articles.

1. Computational analysis of human immunodeficiency virus (HIV) type-1 reverse transcriptase crystallographic models based on significant conserved residues found in highly active antiretroviral therapy (HAART)-treated patients;Alcaro;Curr. Med. Chem.,2010

2. TMC125, a novel next-generation non-nucleoside reverse transcriptase inhibitor active against non-nucleoside reverse transcriptase inhibitor-resistant human immunodeficiency virus type 1;Andries;Antimicrob. Agents Chemother.,2004

3. Drug-resistant mutants of HIV-1 in patients exhibiting increasing CD4 cell count despite virological failure of highly active antiretroviral therapy;Antinori;AIDS,2001

4. Cross-resistance among nonnucleoside reverse transcriptase inhibitors limits recycling efavirenz after nevirapine failure;Antinori;AIDS Res. Hum. Retrovir.,2002

5. Mutants of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase resistant to non-nucleoside reverse transcriptase inhibitors demonstrate altered rates of RNase H cleavage that correlate with HIV-1 replication fitness in cell culture;Archer;J. Virol.,2000

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Meet the Regional Editor;Current Enzyme Inhibition;2022-03

2. Synthesis of 3D cubic of Eu3+/Cu2O with clover-like faces nanostructures and their application as an electrochemical sensor for determination of antiretroviral drug nevirapine;Ceramics International;2021-07

3. Recent Advances in the Design and Development of Non‐nucleoside Reverse Transcriptase Inhibitor Scaffolds;ChemMedChem;2018-12-06

4. The Journey of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) from Lab to Clinic;Journal of Medicinal Chemistry;2018-12-05

5. Enhancement of oral bioavailability of anti-HIV drug rilpivirine HCl through nanosponge formulation;Drug Development and Industrial Pharmacy;2017-09-13